ClinicalTrials.gov
ClinicalTrials.gov Menu

Far Infrared Treatment for Kidney Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00599391
Recruitment Status : Unknown
Verified January 2009 by GAAD Medical Research Institute Inc..
Recruitment status was:  Active, not recruiting
First Posted : January 23, 2008
Last Update Posted : January 5, 2009
Sponsor:
Information provided by:
GAAD Medical Research Institute Inc.

Brief Summary:
Renal failure or kidney failure is a situation in which the kidneys fail to function adequately. It is divided into acute and chronic forms; either form may be due to a large number of other medical problems.

Condition or disease Intervention/treatment Phase
Kidney Failure Radiation: Far Infrared Radiation (5μm to 20μm wavelength) Phase 1

Detailed Description:

There are many causes of chronic kidney disease. The most common cause is diabetes mellitus. Acute renal failure is a rapidly progressive loss of renal function, generally characterized by body fluids disturbances and electrolyte derangement.

It is believed that far infrared radiation of the central nervous system, the endocrine system and the kidneys will help in the management of renal failure and a possible cure.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Phase 1 Study to Examine the Use of Far Infrared Radiation for Renal Failure.
Study Start Date : February 2008
Estimated Primary Completion Date : October 2008
Estimated Study Completion Date : February 2009

Arm Intervention/treatment
1
Far Infrared Radiation
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Far Infrared Radiation for 30 to 40 minutes per session.



Primary Outcome Measures :
  1. Kidney Function Improvement [ Time Frame: 1 year ]

Secondary Outcome Measures :
  1. Causes of Mortality [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • People with kidney diseases

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00599391


Locations
Canada, Ontario
The Centre for Incurable Diseases
Toronto, Ontario, Canada, M4V 1L5
Sponsors and Collaborators
GAAD Medical Research Institute Inc.
Investigators
Study Chair: Ken Nedd, M.D. GAAD Medical Research Institute Inc.
Study Director: Kwasi Donyina, Ph.D. GAAD Medical Research Institute Inc.

Responsible Party: Dr. Kwasi Donyina/Founder and President, GAAD Medical Research Institute Inc.
ClinicalTrials.gov Identifier: NCT00599391     History of Changes
Other Study ID Numbers: GAAD-RF-CTP1
First Posted: January 23, 2008    Key Record Dates
Last Update Posted: January 5, 2009
Last Verified: January 2009

Keywords provided by GAAD Medical Research Institute Inc.:
KIDNEY FAILURE, ACUTE
KIDNEY FAILURE, CHRONIC
RENAL INSUFFICIENCY

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases